Insempra
Insempra enables businesses to transform their ingredient lists away from harmful chemicals and pollutants to superior natural ingredients at an industrial scale.
Insempra has raised €19M across 1 funding round from 8 investors, most recently a Series A round in May 2024. Based in Berlin, Germany; active in Healthtech. Data as of 28 Oct 2026.
Berlin, Germanyinsempra.bio ↗
Total raised
€19M
€18,616,774
Funding rounds
1
Investors
8
distinct backers
Active since
2024-05
latest 2024-05
Funding by year
EUR raised per yearInsempra — funding by year — interactive chart.
Data table
| Insempra — funding by year | |
|---|---|
| 2024 | €19M |
Signals
High confidenceRaise-next likelihood32
base rate 44% for Series A
- ▼ In typical raise window
- ▼ Low backer re-investment
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-05-08 | Series A | €19M | Acequia Capital,Alante Capital,Bayern Kapital,BlueYard Capital,EQT Ventures,Henkel dx Ventures+2 more | View deal → |
Investors
8Related news
Similar companies
same sector or country- Delivery Hero€7.1BGermany · E-commerce
- Enpal€4.6BGermany · Cleantech
- Auxmoney€3.5BGermany · Fintech
- Helsing€2.9BGermany · AI
- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
Global coverage: FundingData